Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
Clinical trial NCT00944801 · COMPLETED
Trial details
- NCT number
- NCT00944801
- Sponsor
- University of Regensburg
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2009-05-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.